These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25879880)

  • 1. Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study.
    Mellon L; Brewer L; Hall P; Horgan F; Williams D; Hickey A;
    BMC Neurol; 2015 Mar; 15():31. PubMed ID: 25879880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment and medication adherence post-stroke: A five-year follow-up of the ASPIRE-S cohort.
    Rohde D; Gaynor E; Large M; Mellon L; Bennett K; Williams DJ; Brewer L; Hall P; Callaly E; Dolan E; Hickey A
    PLoS One; 2019; 14(10):e0223997. PubMed ID: 31622438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention and cognitive function after stroke: a study protocol for a 5-year follow-up of the ASPIRE-S cohort.
    Rohde D; Williams D; Gaynor E; Bennett K; Dolan E; Callaly E; Large M; Hickey A
    BMJ Open; 2017 Mar; 7(3):e014819. PubMed ID: 28348196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Impairment, Vulnerability, and Mortality Post Ischemic Stroke: A Five-Year Follow-Up of the Action on Secondary Prevention Interventions and Rehabilitation in Stroke (ASPIRE-S) Cohort.
    Gaynor E; Rohde D; Large M; Mellon L; Hall P; Brewer L; Conway O; Hickey A; Bennett K; Dolan E; Callaly E; Williams D
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2466-2473. PubMed ID: 29803601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST).
    Scutt P; Blackburn D; Krishnan K; Ballard C; Burns A; Ford GA; Mant J; Passmore P; Pocock S; Reckless J; Sprigg N; Stewart R; Wardlaw JM; Bath PM
    Trials; 2015 Nov; 16():509. PubMed ID: 26545986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cog-4 has limited diagnostic test accuracy and validity for cognitive assessment in stroke survivors.
    Lees R; Lua J; Melling E; Miao Y; Tan J; Quinn TJ
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1604-10. PubMed ID: 24674952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants, Prevalence, and Trajectory of Long-Term Post-Stroke Cognitive Impairment: Results from a 4-Year Follow-Up of the ARCOS-IV Study.
    Mahon S; Parmar P; Barker-Collo S; Krishnamurthi R; Jones K; Theadom A; Feigin V
    Neuroepidemiology; 2017; 49(3-4):129-134. PubMed ID: 29145207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive function in stroke survivors: A 10-year follow-up study.
    Delavaran H; Jönsson AC; Lövkvist H; Iwarsson S; Elmståhl S; Norrving B; Lindgren A
    Acta Neurol Scand; 2017 Sep; 136(3):187-194. PubMed ID: 27804110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to Rehabilitation at Six Months Post Stroke: A Profile from the Action on Secondary Prevention Interventions and Rehabilitation in Stroke (ASPIRE-S) Study.
    Hall P; Williams D; Hickey A; Brewer L; Mellon L; Dolan E; Kelly PJ; Shelley E; Horgan NF;
    Cerebrovasc Dis; 2016; 42(3-4):247-54. PubMed ID: 27189709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of stroke for caregiver outcomes: findings from the ASPIRE-S study.
    Atteih S; Mellon L; Hall P; Brewer L; Horgan F; Williams D; Hickey A;
    Int J Stroke; 2015 Aug; 10(6):918-23. PubMed ID: 26061711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular cognitive impairment: most useful subtests of the Montreal Cognitive Assessment in minor stroke and transient ischemic attack.
    Bocti C; Legault V; Leblanc N; Berger L; Nasreddine Z; Beaulieu-Boire I; Yaneva K; Boulanger JM
    Dement Geriatr Cogn Disord; 2013; 36(3-4):154-62. PubMed ID: 23900081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke.
    Jacquin A; Binquet C; Rouaud O; Graule-Petot A; Daubail B; Osseby GV; Bonithon-Kopp C; Giroud M; Béjot Y
    J Alzheimers Dis; 2014; 40(4):1029-38. PubMed ID: 24577459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke survivor cognitive decline and psychological wellbeing of family caregivers five years post-stroke: a cross-sectional analysis.
    Rohde D; Gaynor E; Large M; Conway O; Bennett K; Williams DJ; Callaly E; Dolan E; Hickey A
    Top Stroke Rehabil; 2019 Apr; 26(3):180-186. PubMed ID: 30907273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of early blood pressure reduction on cognitive function in patients with acute ischemic stroke.
    Bu X; Zhang Y; Bazzano LA; Xu T; Guo L; Wang X; Zhang J; Cui Y; Li D; Zhang F; Ju Z; Xu T; Chen CS; Chen J; He J
    Int J Stroke; 2016 Dec; 11(9):1009-1019. PubMed ID: 27412188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of the Montreal Cognitive Assessment in acute stroke patients.
    Horstmann S; Rizos T; Rauch G; Arden C; Veltkamp R
    Eur J Neurol; 2014 Nov; 21(11):1387-93. PubMed ID: 25040216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention after ischaemic stroke: the ASPIRE-S study.
    Brewer L; Mellon L; Hall P; Dolan E; Horgan F; Shelley E; Hickey A; Williams D;
    BMC Neurol; 2015 Oct; 15():216. PubMed ID: 26492943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of cognitive impairment 3 months after mild to moderate first-ever stroke: a Community-Based Prospective Study of Nonaphasic English-Speaking Survivors.
    Srikanth VK; Thrift AG; Saling MM; Anderson JF; Dewey HM; Macdonell RA; Donnan GA;
    Stroke; 2003 May; 34(5):1136-43. PubMed ID: 12702832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
    Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
    Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underestimation of cognitive impairments by the Montreal Cognitive Assessment (MoCA) in an acute stroke unit population.
    Chan E; Khan S; Oliver R; Gill SK; Werring DJ; Cipolotti L
    J Neurol Sci; 2014 Aug; 343(1-2):176-9. PubMed ID: 24880539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.